Monday, April 21, 2014 8:07:49 AM
Recent RNA News
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/22/2024 08:05:00 PM
- Avidity Biosciences to Participate in Upcoming Investor Conferences • PR Newswire (US) • 03/27/2024 01:00:00 PM
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 03/21/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:23:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:53:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 12:07:00 PM
- Avidity Biosciences Announces Positive AOC 1001 Long-term Data Showing Reversal of Disease Progression in People Living with Myotonic Dystrophy Type 1 Across Multiple Endpoints; Same Key Endpoints Agreed for Phase 3 HARBOR™ Trial • PR Newswire (US) • 03/04/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:31:50 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/29/2024 09:19:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:06:10 PM
- Avidity Biosciences Honors Rare Disease Day® • PR Newswire (US) • 02/29/2024 05:00:00 PM
- Avidity Biosciences Announces Oversubscribed $400 Million Private Placement • PR Newswire (US) • 02/29/2024 12:00:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 02/28/2024 10:32:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 09:17:47 PM
- Avidity Biosciences Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Highlights • PR Newswire (US) • 02/28/2024 09:05:00 PM
- Avidity Biosciences to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/27/2024 02:00:00 PM
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 02/21/2024 09:05:00 PM
- Avidity Biosciences Receives FDA Rare Pediatric Disease Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy in People with Mutations Amenable to Exon 44 Skipping • PR Newswire (US) • 02/20/2024 02:00:00 PM
- Avidity Biosciences to Present New AOC 1001 Long-term Efficacy and Safety Data from MARINA-OLE™ Trial in People Living with Myotonic Dystrophy Type 1 (DM1) at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference • PR Newswire (US) • 02/15/2024 10:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/02/2024 05:08:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 08:13:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 08:12:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 08:11:51 PM
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 01/22/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 01:36:20 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM